March 1, 2017Open Access

Discovery of Highly Potent 2-Sulfonyl-Pyrimidinyl Derivatives for Apoptosis Inhibition and Ischemia Treatment

Key Points

Key points are not available for this paper at this time.

Abstract

, also named as TC9-305). The therapeutic potential of these new apoptosis inhibitors was further demonstrated by their neuroprotective effect on an ischemic animal model.

Read Full Paperexternally

AI에게 질문

Bookmark

View Full Paper

Cite This Study

Li et al. (Wed,) studied this question.

synapsesocial.com/papers/6a02a6e2bc3ffe278e6515f3 https://doi.org/https://doi.org/10.1021/acsmedchemlett.6b00489

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Focal Cerebral Ischemia Model by Endovascular Suture Occlusion of the Middle Cerebral Artery in the Rat2011 · 107 citations
2Mitochondrial Regulation of Apoptosis2003 · 226 citations
33,6-Dibromocarbazole Piperazine Derivatives of 2-Propanol as First Inhibitors of Cytochrome <i>c</i> Release via Bax Channel Modulation2003 · 90 citations
4Targeting Apoptosis via Chemical Design2004 · 92 citations
5A Comparative Study of Apoptosis and Necrosis in HepG2 Cells: Oxidant-Induced Caspase Inactivation Leads to Necrosis1999 · 203 citations

AI에게 질문

Bookmark

View Full Paper